Hardy Reed’s NRC Health Common Stock NRC Stock Holding History

Hardy Reed’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-932	Closed	-$42K	–	79
2020 Q1	$42K	Buy	+932	New	+$56K	0.02%	64

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hardy Reed's NRC Position: Q2 2020 in Review

Hardy Reed sold out of NRC Health Common Stock (NRC) in Q2 2020, closing a stake of 932 shares — an estimated $42K sold.

Hardy Reed first reported a position in NRC in Q1 2020 and held it in 1 quarter. The position peaked at $42K in Q1 2020. 95 funds tracked by Wall St. Rank hold NRC as of Q2 2020.

Hardy Reed reported no remaining NRC Health Common Stock position as of Q2 2020 after selling out during the quarter.
Hardy Reed sold 932 NRC Health Common Stock shares in Q2 2020, an estimated $42K.
Hardy Reed first reported a position in NRC Health Common Stock in Q1 2020 and held it in 1 quarter.
Hardy Reed's NRC Health Common Stock position peaked at $42K in Q1 2020.
95 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2020.

Based on Hardy Reed's 13F filing for Q2 2020, filed 20 Jul 2020.